Liat Nachshon

14PUBLICATIONS
11CO-AUTHORS
AllergyFood safety, traceability, certification and authenticityHorticultural crop protection (incl. pests, diseases and weeds)Infant and child healthPacific Peoples youth and family
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 02, 2026
Inhibition studies to direct oral immunotherapy in walnut-hazelnut co-allergic patients (nut CRACKER study).

|Jun 12, 2026
Cashew Reaction Thresholds, Its Predictors, and Very Low Validated Safe Doses, in a Large Allergic Population (Nut CRACKER Study).

|Nov 20, 2025
Decreased Severity of Oral Immunotherapy Induced Gastrointestinal Eosinophilic Reactions Following Revisions in Milk-Treatment Protocol.

Na'ama Epstein-Rigbi, Matan Elkan, Yair Tzarfati

|Aug 22, 2023
Sesame eliciting and safe doses in a large sesame allergic population.

Liat Nachshon, Joost Westerhout, W Marty Blom

|Oct 03, 2022
Efficacy and safety of food allergy oral immunotherapy in adults.

Na'ama Epstein-Rigbi, Michael B Levy, Liat Nachshon

|Jan 09, 2022
Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study).

Arnon Elizur, Michael Y Appel, Liat Nachshon

Pageof 3

Frequent Collaborators

10 joint publications

Michael R Goldberg

9 joint publications

Arnon Elizur

8 joint publications

Naama Epstein-Rigby

2 joint publications

Michael Y Appel